NF-κB/PPARγ and/or AP-1/PPARγ ‘on/off’ switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression
- 25 February 2006
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 22 (1) , 57-68
Abstract
Background and aims Several studies indicate that peroxisome proliferator-activated receptor gamma (PPARγ) represses activator protein-1 (AP-1) and nuclear factor kappa B (NF-κB) transcriptional activity and this negative cross-talk occupies an important role in carcinogenesis. The present study evaluated the differential expression profile of AP-1 constituents (c-FOS and phosphorylated-active pc-JUN), p-IκB-α (phosphorylated IκB-α, a signaling intermediate of NF-κB pathway), PPARγ, cyclic AMP-response element binding-binding protein (CBP, a known AP-1, NF-κB, and PPARγ transcriptional coactivator), epidermal growth factor receptor (EGF-R), p53, and COX-2 in normal colonic epithelial cells and colon adenocarcinoma cells. Materials and methods Immunohistochemical methodology was performed on formalin-fixed, paraffin-embedded sections from 60 patients with colon adenocarcinomas. A molecular profile was created for each patient and the induction or down-regulation of each pathway from normal to cancer cells was documented. Relationships between transcription factors and downstream molecular targets were evaluated by Spearman’s rho correlation coefficient and validated by nonparametric Kruskal–Wallis test. Results/findings P-IκB-α (PPP=0.047), pc-JUN (P=0.047), and EGF-R (PP<0.001) was concomitantly down-regulated. p-IκB-α, CBP, pc-JUN, EGF-R, and p53 expression all correlated positively with COX-2 while PPARγ expression correlated inversely with COX-2. Interpretation/conclusion NF-κB/PPARγ and/or AP-1/PPARγ expressional ‘on/off’ switches are common molecular events during colorectal carcinogenesis. Down-regulation of PPARγ and induction of the CBP transcriptional coactivator can augment NF-κB and AP-1 transcriptional activities leading to up-regulation of COX-2 expression in colon adenocarcinoma cells. p-IκB-α, pc-JUN, and CBP could potentially provide the basis for future molecular-targeted anticancer therapies.Keywords
This publication has 43 references indexed in Scilit:
- AP-1: a double-edged sword in tumorigenesisNature Reviews Cancer, 2003
- AP-1 as a regulator of cell life and deathNature Cell Biology, 2002
- Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast CancerJournal of Biological Chemistry, 2002
- Induction of the CBP transcriptional co-activator early during laryngeal carcinogenesisJournal of Cancer Research and Clinical Oncology, 2002
- Activator Protein-1 Transcription Factor Mediates Bombesin-stimulated Cyclooxygenase-2 Expression in Intestinal Epithelial CellsJournal of Biological Chemistry, 2001
- AP-1 in cell proliferation and survivalOncogene, 2001
- Oxidized Low Density Lipoprotein Inhibits Interleukin-12 Production in Lipopolysaccharide-activated Mouse Macrophages via Direct Interactions between Peroxisome Proliferator-activated Receptor-γ and Nuclear Factor-κBJournal of Biological Chemistry, 2000
- Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activationOncogene, 2000
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Activation of cAMP and mitogen responsive genes relies on a common nuclear factorNature, 1994